Quarterly Financial Results for Q2 2026 – This 10-Q filing covers Colgate-Palmolive's financial performance for the six-month period ending June 30, 2026, and the second quarter specifically (April 1 - June 30, 2026), with comparative periods from 2025 Consolidated Balance Sheet and Statement of Equity – Contains detailed financial position data as of June 30, 2026 and December 31, 2025,…

Our analysis rates this filing CAUTIOUS. The elevated concern level (6.8/10) is justified by multiple compounding risk factors. The company faces a significant restructuring program (severity 7) with uncertain total cost exposure across geographically dispersed operations, coinciding with a recent…

Concern level: HIGH (6.8/10). Key factors: One high-severity risk identified: Strategic Restructuring Program (severity 7/10) with material cost exposure across multiple geographies and business segments, with range-based estimates indicating significant uncertainty in final costs; Risk trend is INCREASING with overall risk score of 6.8/10, suggesting deteriorating business conditions; Recent…

Notable risk changes: Strategic Growth and Productivity Program initiated with multi-region restructuring (North America, Latin America, EMEA, Asia Pacific) and multi-segment impact (Hills Pet Nutrition, Corporate), indicating significant operational transformation with uncertain total cost exposure; Recent CareTops Pty Ltd acquisition (April 2025) disclosed with minimal integration detail, creating near-term…

The model predicts CL will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.